Comprehensive analysis of unique cases with extraordinary control over HIV replication.
about
Altered antibody profiles against common infectious agents in chronic diseaseQuantitative humoral profiling of the HIV-1 proteome in elite controllers and patients with very long-term efficient antiretroviral therapy.Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient.Autograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients.Luciferase immunoprecipitation systems for measuring antibodies in autoimmune and infectious diseases.Lack of Evidence for Molecular Mimicry in HIV-Infected Subjects.Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infectionThe Cancer-Associated Virus Landscape in HIV Patients with Oral Hairy Leukoplakia, Kaposi's Sarcoma, and Non-Hodgkin Lymphoma.The potential complexity and need for caution when interpreting atypical human immunodeficiency virus reactivity in blood donors.Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.Monitoring Integration over Time Supports a Role for Cytotoxic T Lymphocytes and Ongoing Replication as Determinants of Reservoir Size.HIV antibody characterization as a method to quantify reservoir size during curative interventions.The implications of viral reservoirs on the elite control of HIV-1 infection.HIV and HLA class I: an evolving relationshipHIV controllers: a genetically determined or inducible phenotype?Unravelling the mechanisms of durable control of HIV-1.The role of MHC class I gene products in SIV infection of macaques.Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART.HIV Persistence in Gut-Associated Lymphoid Tissues: Pharmacological Challenges and Opportunities.Primary CD8+ T cells from elite suppressors effectively eliminate non-productively HIV-1 infected resting and activated CD4+ T cells.Innate and Adaptive Immunity in Long-Term Non-Progression in HIV Disease.Prevalence of human immunodeficiency virus RNA and antibody in first-time, lapsed, and repeat blood donations across five international regions and relative efficacy of alternative screening scenarios.What Is the most Important for Elite Control: Genetic Background of Patient, Genetic Background of Partner, both or neither? Description of Complete Natural History within a Couple of MSM.Measuring integrated HIV DNA ex vivo and in vitro provides insights about how reservoirs are formed and maintained.T cell receptors for the HIV KK10 epitope from patients with differential immunologic control are functionally indistinguishable.Anti-Human Immunodeficiency Virus Antibodies in the Cerebrospinal Fluid: Evidence of Early Treatment Impact on Central Nervous System Reservoir?Sustained Viremic Control in HIV-Infected Patient: Case Report from Nepal.HIV control: Is getting there the same as staying there?
P2860
Q28661374-15153E6F-A09A-4ED5-BDC6-5514876B6122Q33677727-8C25EDFA-A386-44F9-8E92-965EBDDF011AQ34611170-D7310AE2-8739-4B8B-820F-7F740589508BQ34720281-5A46F168-7D61-48E5-9CD4-C3B9A3CB9540Q34869326-F1174C9B-DE64-4472-A1C7-033D3869CF32Q35013894-F7BEC7AB-A8A6-44C5-9B4A-F2DD053B015FQ35849605-F948EA76-7516-415C-A746-1B39DBCC06CFQ36096177-2ECB527F-D47F-4CF3-BC7E-EE654F8B7D4BQ36178032-8C4224CD-6108-4D18-9B15-509F83363B3DQ36220101-A0985CAD-F7FD-4B74-A4E3-6CD885A2230EQ37161557-29FB6687-6D3E-4A3A-9506-8FD265E3C178Q37415458-ED538AA8-1C5E-4635-88C7-7696DB7CDFCDQ37719743-233CD081-3A9D-469A-9877-D5C770AD7420Q38032153-09C124E9-86FF-4B44-80FF-DFDD37972375Q38045636-8DAD1C80-EB1E-46E5-A295-906AD7A8953EQ38114915-F49DFD23-9C1B-4706-82D7-F5198E11BFCDQ38116710-513E8A5B-C1A4-40EF-8D19-97F0D517022DQ39427566-BC1FB43F-3DB3-4E4C-97FE-A5F0EA644CCBQ40192992-FCB79EBE-CBFF-425E-98D6-FBED9CECB416Q40256176-46B9444E-B685-4160-B366-AA55ACD16B18Q41915015-76EC6240-5BDB-4C45-B8A8-B6A26F270833Q42130441-3E393E14-CFF6-4D88-9A6B-8F9003335664Q42258338-233EDF69-181B-4753-B45B-EE0BFABD619FQ47561102-6E5B9711-1435-421B-AFDD-611C320DA17BQ49920984-6E913DD5-5E6F-49CB-B52B-B0BCE8936466Q50043370-3A4D4F79-E597-4FA0-A3DD-5E3A104E9742Q52699607-54A53BC4-BDC0-41B7-989F-FF47C5B53027Q55219748-AB27108C-C743-49C7-9A83-E1AF49647AC9Q58085173-DA1CEF06-B294-4813-BCC9-DA0979E9F3A5
P2860
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
@ast
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
@en
type
label
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
@ast
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
@en
prefLabel
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
@ast
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
@en
P2093
P2860
P50
P1433
P1476
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
@en
P2093
Bennett A Peterson
Catherine A Rehm
Cheryl L Chairez
Erin H Graf
Jamieson H Greenwald
Jessica N Hodge
Joseph A Kovacs
Maria Salgado
Mark Connors
Nancy A Cogliano
P2860
P304
P356
10.1182/BLOOD-2011-10-381996
P407
P577
2012-04-05T00:00:00Z